Saturday 4th February 2017 marks World Cancer Day – an annual initiative where the global cancer community comes together to unite the world’s population in fighting cancer through awareness raising and education.
At Novartis, World Cancer Day is an opportunity to reflect on the importance of the work we do each day. Whether it’s through our research, our work with patients, a personal diagnosis or the diagnosis of a friend, colleague or loved one – we’ve all been touched by cancer in some way and our mission is to help improve the lives of cancer patients.
We are committed to the discovery and development of innovative medicines that transform the way people live with cancer. We seek to provide a wide range of innovative medicines to help address unmet medical needs, as well as provide practical solutions to advance the care of patients.
We offer one of the largest portfolios of medicines in oncology and with new molecules in development targeting key molecular pathways in cancer biology, we believe the opportunity to improve patient outcomes has never been greater.
At Novartis, we are all connected by our commitment to patients. Our extraordinarily talented and diverse employees are dedicated to helping improve the lives of cancer patients through shared goals and different perspectives. Together, we innovate to deliver for our customers so we can improve and extend the lives of people living with cancer. By working together, we can make a difference.
Novartis is passionate about discovering new ways to support people affected by cancer. We understand that people living with cancer need information, support and tools so that they can be empowered to understand not only their disease, but also their specific tumor type so that they can have informed conversations with their healthcare professionals and explain their treatment goals. We work with UK patient support groups to help us to better understand the needs of people living with certain diseases and how we can help deliver improved care and resources for patients.
Our work currently spans across the following areas; ALK+ advanced non-small cell lung cancer, Bone metastasis, Chronic myeloid leukemia, Gastrointestinal stromal tumors, Metastatic Melanoma, Multiple Myeloma, Myelofibrosis, Neuroendocrine tumors, Polycythemia Vera, Renal Cell Carcinoma, SEGA Tumors and Soft Tissue Sarcoma.
Join the World Cancer Day movement by sharing on social media what cancer means to you and show your support using the hashtags #WorldCancerDay #WeCanICan.
We joined the movement by asking our Novartis UK associates what working in cancer means to them. Follow @NovartisUK on Twitter to hear what they shared.
It is impossible to live a life unaffected by cancer. Myself and my family have been touched by both the sadness of loss and the triumph of treatment through the course of our lives. What makes today special for me, is the chance to say thank you to everyone at Novartis for the work we each do every day. We are working to transform science into innovative solutions that meet the needs of our customers, so that together we improve care for people living with cancer.